{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-09T12:25:33.966020+00:00",
  "news": [
    {
      "title": "Fayez Sarofim & Co Acquires 18,213 Shares of Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPb2NGRm5BdFE4NjNIeXk0MlhyYzYtYzROZkR5OHFBZmxKdHFRR196cDZxSnFJRUpoT2FVVWxwYURfVzdtUHpSZlRZUXV3X3IxdEVscE9BMmdZVkQyWGhEQXRmeFhxVzdoZlFxbXhoSzhQZERkdC1BcGJoMmZLUmY1NWlzekFWT05SeVowYnRINnBJZHdrZW92SlZQYnNsZVlBdXpGRnNuQzZDTUdDbDRYQzJienFha2Z0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPb2NGRm5BdFE4NjNIeXk0MlhyYzYtYzROZkR5OHFBZmxKdHFRR196cDZxSnFJRUpoT2FVVWxwYURfVzdtUHpSZlRZUXV3X3IxdEVscE9BMmdZVkQyWGhEQXRmeFhxVzdoZlFxbXhoSzhQZERkdC1BcGJoMmZLUmY1NWlzekFWT05SeVowYnRINnBJZHdrZW92SlZQYnNsZVlBdXpGRnNuQzZDTUdDbDRYQzJienFha2Z0?oc=5\" target=\"_blank\">Fayez Sarofim & Co Acquires 18,213 Shares of Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-09T10:36:11+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5\" target=\"_blank\">Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-05T14:11:59+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen inks LA sports, entertainment partnership, setting up 2026 World Cup presence - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQUEFNV1gyZ1l4cXR6dkdNRENsM1FXN2xDLVFEVXZZVEJmbjU5OTNKZDBVUERuazlFUWFtVVl4aU9xQkpUbG5pNS1rV0tTaUVCSDNhSWFyMlpOVnBqcS13UDc5TjlCb3hOUG5LNHlYN0RRZEhvUV9kWU16Q2NoWjRfRkN1S0xoSnBZUjlrMWE5dHgyV1pONV90eWxZMzZ5N19jWE5fOXBjM3FDSW9tODg1a25RSENzQi16?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQUEFNV1gyZ1l4cXR6dkdNRENsM1FXN2xDLVFEVXZZVEJmbjU5OTNKZDBVUERuazlFUWFtVVl4aU9xQkpUbG5pNS1rV0tTaUVCSDNhSWFyMlpOVnBqcS13UDc5TjlCb3hOUG5LNHlYN0RRZEhvUV9kWU16Q2NoWjRfRkN1S0xoSnBZUjlrMWE5dHgyV1pONV90eWxZMzZ5N19jWE5fOXBjM3FDSW9tODg1a25RSENzQi16?oc=5\" target=\"_blank\">Amgen inks LA sports, entertainment partnership, setting up 2026 World Cup presence</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-08T16:17:14+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Why Is Amgen (AMGN) Up 8% Since Last Earnings Report? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9abjlYSlh2YUozNU0zNjFQZ1ZXSlVaTjRVRU9TZEpuME90LXF3MkJDaFhaNnlBaHI5R3pjQWVkU1BPcW9KV1VQRjR4SG9LTHVnemdFcEZlOTFkQjRzM19SZHBrNlFRZDJsZmJVWnE0a1phTlFlZzE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE9abjlYSlh2YUozNU0zNjFQZ1ZXSlVaTjRVRU9TZEpuME90LXF3MkJDaFhaNnlBaHI5R3pjQWVkU1BPcW9KV1VQRjR4SG9LTHVnemdFcEZlOTFkQjRzM19SZHBrNlFRZDJsZmJVWnE0a1phTlFlZzE0?oc=5\" target=\"_blank\">Why Is Amgen (AMGN) Up 8% Since Last Earnings Report?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-04T16:30:07+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-05T18:48:38+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "CEO of drugmaker Amgen talks new results from cholesterol drug trial - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5\" target=\"_blank\">CEO of drugmaker Amgen talks new results from cholesterol drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen Inc. $AMGN Shares Purchased by Daiwa Securities Group Inc. - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQcFFTenZqMGVaZWFZLWJ3NnIzRFdKWlhLSzNucHZRT1J6Q0o3ZDA3VlUwSjMyalNRVkxfTVBVRVc1TldPbkY0WFhPNldsZXNKaHpDc3h3NzhETldGOURWa3F1MnRxOGFQaFczU28xeXp4X3BKNXpxa0JHZ2N6SmFoVmxSdW5rWUppZjU2czVaZ21rcGpuQWJtVGk0RFB4TGo3anI4WlQ2S09vZ1Q1dVN4UmNCWFlubTd1TmhIMVMzNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQcFFTenZqMGVaZWFZLWJ3NnIzRFdKWlhLSzNucHZRT1J6Q0o3ZDA3VlUwSjMyalNRVkxfTVBVRVc1TldPbkY0WFhPNldsZXNKaHpDc3h3NzhETldGOURWa3F1MnRxOGFQaFczU28xeXp4X3BKNXpxa0JHZ2N6SmFoVmxSdW5rWUppZjU2czVaZ21rcGpuQWJtVGk0RFB4TGo3anI4WlQ2S09vZ1Q1dVN4UmNCWFlubTd1TmhIMVMzNA?oc=5\" target=\"_blank\">Amgen Inc. $AMGN Shares Purchased by Daiwa Securities Group Inc.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-09T10:29:02+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNc0pjZjFhcktfYnNMRFdIb3pOOFR5bXBGQzlzWjQ5WXhuX0dDSUdMRTM5bXZ0cVdPYWRaWUZoX25RVXRmX1EwVTVtblVUcHdSQU12WndmU1d2UWlpSUpBMDVoVnFnLXJGR243LWswYlVXRDJVZlgwLTFDeFFDd0NhYlV3TE8tQTlfNklyRXVfQWdqbkVPNGl2Z1M2TUFnQnp5dW40?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNc0pjZjFhcktfYnNMRFdIb3pOOFR5bXBGQzlzWjQ5WXhuX0dDSUdMRTM5bXZ0cVdPYWRaWUZoX25RVXRmX1EwVTVtblVUcHdSQU12WndmU1d2UWlpSUpBMDVoVnFnLXJGR243LWswYlVXRDJVZlgwLTFDeFFDd0NhYlV3TE8tQTlfNklyRXVfQWdqbkVPNGl2Z1M2TUFnQnp5dW40?oc=5\" target=\"_blank\">Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-02T13:00:35+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-09",
      "close": 321.2300109863281
    },
    "history": [
      {
        "date": "2025-11-28",
        "close": 345.4599914550781
      },
      {
        "date": "2025-12-01",
        "close": 337.489990234375
      },
      {
        "date": "2025-12-02",
        "close": 338.3599853515625
      },
      {
        "date": "2025-12-03",
        "close": 345.4200134277344
      },
      {
        "date": "2025-12-04",
        "close": 340.1600036621094
      },
      {
        "date": "2025-12-05",
        "close": 329.8900146484375
      },
      {
        "date": "2025-12-08",
        "close": 321.2300109863281
      },
      {
        "date": "2025-12-09",
        "close": 321.2300109863281
      }
    ],
    "name": "Amgen Inc."
  }
}